Description
GHRP-2 is a synthetic hexapeptide classified as a growth hormone secretagogue that acts as an agonist of the ghrelin/growth hormone secretagogue receptor (GHSR1a). In experimental systems, receptor activation is commonly associated with increased intracellular signaling and measurable changes in pituitary hormone release, making GHRP-2 a useful tool for studying endocrine receptor pathways. GHRP-2 peptide research typically focuses on the neuroendocrine regulation of growth hormone secretion, ghrelin-receptor pharmacology, and downstream signaling dynamics relevant to the somatotropic axis.
In laboratory research, the compound is used to probe receptor binding, signal transduction, and secretion kinetics in controlled models. Major research areas include (1) GPCR activation and desensitization studies, (2) hypothalamic–pituitary signaling and hormone pulse characterization, and (3) metabolic and appetite-related pathway mapping in preclinical models. These systems matter in laboratory research because they provide measurable endpoints for receptor function, endocrine feedback control, and signaling specificity under standardized conditions.
For research use only. Not for human consumption.
References:
Bowers CY et al., Endocrinology, 1990 126(3):1223–1228
Jacks T et al., Endocrinology, 1994 134(2):744–750
Smith RG et al., Science, 1997 275(5304):1261–1264




Reviews
There are no reviews yet.